Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache
{{output}}
Background: Galcanezumab of 300 mg monthly is the FDA approved preventive medication for cluster headache (CH) during the cluster period. Compared to the 120 mg galcanezumab syringe for the treatment of migraines, the 100 mg syri... ...
